Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate

This publication has 9 references indexed in Scilit:

• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
  Journal of Clinical Oncology, 1989
• 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
• Comparison of 32P Therapy and Sequential Hemibody Irradiation (HBI) for Bony Metastases as Methods of Whole Body Irradiation
  American Journal of Clinical Oncology, 1986
• Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
  Radiology, 1980
• Half body radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1976
• Testosterone potentiated32P therapy in prostatic carcinoma
  Cancer, 1966
• THE USE OF P32IN THE TREATMENT OF SEVERE PAIN FROM BONE METASTASES OF CARCINOMA OF THE PROSTATE1
  British Journal of Urology, 1965
• The Use of Radioactive Phosphorus and Testosterone in Metastatic Bone Lesions from Breast and Prostate
  Southern Medical Journal, 1958